Calcium–phosphorus product concentration is a risk factor of coronary artery disease in metabolic syndrome
Authors:
- Dong-Hyun LeeDLDong-Hyun Lee
- Ho-Joong YounHYHo-Joong Youn
- 1 July 2013
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 229 (1) , 253-257
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Phosphorus Is Associated with Coronary Artery Disease in Patients with Preserved Renal FunctionPLOS ONE, 2012
- Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the ElderlyJACC, 2010
- Vascular calcification in chronic kidney diseaseClinical Science, 2010
- Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitroKidney International, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Cardiac calcification in adult hemodialysis patientsJACC, 2002
- Quantification of coronary artery calcium using ultrafast computed tomographyJACC, 1990